Multi event Drug Recall Enforcement Report Class II voluntary initiated by Fresenius Kabi USA, LLC, originally initiated on 11-22-2022 for the product Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%, 250 mg per 50 mL (5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-463-01), packaged in 25 Multiple Dose Vials per tray (NDC 63323-463-57), Rx only, Fresenius Kabi, Lake Zurich, IL 60047. The product was recalled due to subpotent drug: testing results below the defined limit for the epinephrine portion of this product.. The product was distributed nationwide and the recall is currently terminated.
Recall Enforcement Reports
Recall Number |
Recall Initiation Date |
Report Date |
Recall Classification |
Quantity |
Product Description |
Recall Reason |
Status |
D-0128-2023 | 11-22-2022 | 01-25-2023 | Class II | 40,025 vials | Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%, 250 mg per 50 mL (5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-463-01), packaged in 25 Multiple Dose Vials per tray (NDC 63323-463-57), Rx only, Fresenius Kabi, Lake Zurich, IL 60047. | Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product. | Terminated |
D-0127-2023 | 11-22-2022 | 01-25-2023 | Class II | 40,375 vials | Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 125 mg per 50 mL (2.5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-461-01), packaged in 25 Multiple Dose Vials per tray (NDC 63323-461-57), Rx only, Fresenius Kabi, Lake Zurich, IL 60047. | Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product. | Terminated |
D-0129-2023 | 11-22-2022 | 01-25-2023 | Class II | 31,600 vials | Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 25 mg per 10 mL (2.5 mg per mL), 10 mL Single Dose Vial (NDC 63323-468-01), packaged in 25 Single Dose Vials per tray (NDC 63323-468-17), Rx only, Fresenius Kabi, Lake Zurich, IL 60047. | Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product. | Terminated |
Recalled Products
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Product Type |
63323-461 | Sensorcaine | | | | App Pharmaceuticals, Llc | |
63323-461 | Sensorcaine | Bupivacaine Hydrochloride And Epinephrine Bitartrate | Injection, Solution | Infiltration; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-463 | Sensorcaine | | | | App Pharmaceuticals, Llc | |
63323-463 | Sensorcaine | Bupivacaine Hydrochloride And Epinephrine Bitartrate | Injection, Solution | Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-468 | Sensorcaine MPF | | | | App Pharmaceuticals, Llc | |
63323-468 | Sensorcaine MPF | Bupivacaine Hydrochloride And Epinephrine Bitartrate | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-468 | Sensorcaine MPF | Bupivacaine Hydrochloride And Epinephrine Bitartrate | Injection, Solution | Epidural; Infiltration; Intracaudal; Perineural | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-472 | Sensorcaine MPF | | | | App Pharmaceuticals, Llc | |
63323-472 | Sensorcaine MPF | | | | App Pharmaceuticals, Llc | |
63323-472 | Sensorcaine MPF | Bupivacaine Hydrochloride | Injection, Solution | Epidural; Retrobulbar | Fresenius Kabi Usa, Llc | Human Prescription Drug |